Gene · 6080
Papers2,015
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
201 to 220 of 2,015
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Remission of liquid tumors and SARS-CoV-2 infection: A literature review. | Mol Ther Oncolytics | 2022 | 35702422 | PubTator, text mining | PubMed |
| Praja1 RING-finger E3 ubiquitin ligase is a common suppressor of neurodegenerative disease-associated protein aggregation. | Neuropathology | 2022 | 35701899 | PubTator, text mining | PubMed |
| PML Alternative Splice Products Differentially Regulate HAdV Productive Infection. | Microbiol Spectr | 2022 | 35699431 | PubTator, text mining | PubMed |
| Emerging Therapies for Hepatocellular Carcinoma (HCC). | Cancers (Basel) | 2022 | 35681776 | PubTator, text mining | PubMed |
| A qPCR-Based Method for Quantification of RCA Contaminants in Oncolytic Adenovirus Products. | Front Mol Biosci | 2022 | 35677885 | PubTator, text mining | PubMed |
| Knockdown of E1- and E2-ubiquitin enzymes triggers defective chorion biogenesis and modulation of autophagy-related genes in the follicle cells of the vector Rhodnius prolixus. | J Cell Physiol | 2022 | 35670557 | PubTator, text mining | PubMed |
| Research on Knowledge, Attitudes, and Practices of Influenza Vaccination Among Healthcare Workers in Chongqing, China-Based on Structural Equation Model. | Front Public Health | 2022 | 35664097 | PubTator, text mining | PubMed |
| Nuclear antiviral innate responses at the intersection of DNA sensing and DNA repair. | Trends Microbiol | 2022 | 35641341 | PubTator, text mining | PubMed |
| Remodeling the tumor microenvironment by oncolytic viruses: beyond oncolysis of tumor cells for cancer treatment. | J Immunother Cancer | 2022 | 35640930 | PubTator, text mining | PubMed |
| Endoscopic ultrasound guided interventions in the management of pancreatic cancer. | World J Gastrointest Endosc | 2022 | 35634485 | PubTator, text mining | PubMed |
| Intratumoral delivery of a novel oncolytic adenovirus encoding human antibody against PD-1 elicits enhanced antitumor efficacy. | Mol Ther Oncolytics | 2022 | 35615266 | PubTator, text mining | PubMed |
| Modulation of p53 expression in cancer-associated fibroblasts prevents peritoneal metastasis of gastric cancer. | Mol Ther Oncolytics | 2022 | 35615263 | PubTator, text mining | PubMed |
| Oncolytic viral vectors in the era of diversified cancer therapy: from preclinical to clinical. | Clin Transl Oncol | 2022 | 35612653 | PubTator, text mining | PubMed |
| Adenoviral vectors for cardiovascular gene therapy applications: a clinical and industry perspective. | J Mol Med (Berl) | 2022 | 35606652 | PubTator, text mining | PubMed |
| Ixovex-1, a novel oncolytic E1B-mutated adenovirus. | Cancer Gene Ther | 2022 | 35596069 | PubTator, text mining | PubMed |
| Efficacy and Safety of Recombinant Human Adenovirus Type 5 (H101) in Persistent, Recurrent, or Metastatic Gynecologic Malignancies: A Retrospective Study. | Front Oncol | 2022 | 35574359 | PubTator, text mining | PubMed |
| Eutectic Thin-Layer Chromatography as a New Possibility for Quantification of Plant Extracts-A Case Study. | Molecules | 2022 | 35566305 | PubTator, text mining | PubMed |
| snoRNAs: functions and mechanisms in biological processes, and roles in tumor pathophysiology. | Cell Death Discov | 2022 | 35552378 | PubTator, text mining | PubMed |
| Trovafloxacin drives inflammation-associated drug-induced adverse hepatic reaction by changing macrophage polarization. | Toxicol In Vitro | 2022 | 35537566 | PubTator, text mining | PubMed |
| SAKK 35/15: a phase 1 trial of obinutuzumab in combination with venetoclax in patients with previously untreated follicular lymphoma. | Blood Adv | 2022 | 35537101 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/6080/papers?page=11